www.fdanews.com/articles/122307-xeomin-approved-for-new-indication-in-eu
Xeomin Approved for New Indication in EU
November 18, 2009
Merz Pharmaceuticals announced that European health authorities have reached an agreement on
a new indication of Xeomin for the symptomatic treatment of post-stroke spasticity of the upper limb presenting with flexed wrist and clenched fist in
adults.
CNW Group
CNW Group